HSIC · Henry Schein Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.81B |
| R&D | - | - | - | - | - | - |
| SG&A | $3.08B | $3.03B | $2.96B | $2.77B | $2.81B | $2.25B |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $311.00M | $297.00M | $248.00M | $212.00M | $209.53M | $185.54M |
| Operating Income | $653.00M | $621.00M | $615.00M | $747.00M | $851.66M | $535.30M |
| Interest Expense | $150.00M | $131.00M | $87.00M | $44.00M | $27.60M | $41.38M |
| Income Tax | $126.00M | $128.00M | $120.00M | $170.00M | $197.35M | $95.37M |
| Net Income | $398.00M | $390.00M | $416.00M | $538.00M | $631.23M | $403.79M |
| EPS - Basic | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 |
| EPS - Diluted | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $156.00M | $122.00M | $171.00M | - | - | $421.19M |
| Accounts Receivable | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B |
| Accounts Payable | $1.15B | $962.00M | $1.02B | $1.00B | $1.05B | $1.01B |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B |
| Long-term Debt | - | - | - | $822.00M | - | - |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.80B | $3.46B |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.43B | $3.35B |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $712.00M | $848.00M | $500.00M | $602.00M | $709.58M | $598.91M |
| Investing Cash Flow | ($400.00M) | ($430.00M) | ($1.14B) | ($276.00M) | ($677.22M) | ($115.02M) |
| Financing Cash Flow | ($188.00M) | ($510.00M) | $701.00M | ($315.00M) | ($332.96M) | ($187.19M) |
| CapEx | $139.00M | $148.00M | $147.00M | $96.00M | $79.02M | $48.83M |
| Free Cash Flow | $573.00M | $700.00M | $353.00M | $506.00M | $630.57M | $550.08M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% |
| Operating margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% |
| EBITDA margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% |
| Net margin | 3.0% | 3.1% | 3.4% | 4.3% | 5.1% | 4.0% |
| Free cash flow margin | 4.3% | 5.5% | 2.9% | 4.0% | 5.1% | 5.4% |
| FCF / Net income | 1.44 | 1.79 | 0.85 | 0.94 | 1.00 | 1.36 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 23.4% | 23.9% | 24.0% | 21.9% | 22.7% | 22.2% |
| Effective tax rate | 24.0% | 24.7% | 22.4% | 24.0% | 23.8% | 19.1% |
| Return on assets | 3.5% | 3.8% | 3.9% | 6.3% | 7.4% | 5.2% |
| Return on equity | 12.3% | 11.5% | 11.4% | 15.6% | 18.4% | 12.1% |
| Return on invested capital | - | - | - | 13.3% | - | - |
| Liquidity | ||||||
| Current ratio | 1.38 | 1.42 | 1.67 | 1.79 | 1.67 | 1.66 |
| Quick ratio | 0.76 | 0.78 | 1.00 | 0.91 | 0.86 | 1.00 |
| Cash ratio | 0.05 | 0.04 | 0.06 | - | - | 0.18 |
| Leverage | ||||||
| Debt / Equity | - | - | - | 0.24 | - | - |
| Debt / Assets | - | - | - | 0.10 | - | - |
| Debt / EBITDA | - | - | - | 0.86 | - | - |
| Interest coverage | 4.4x | 4.7x | 7.1x | 17.0x | 30.9x | 12.9x |
| Equity multiplier | 3.46 | 3.01 | 2.89 | 2.50 | 2.48 | 2.32 |
| Liabilities / Assets | 0.57 | 0.53 | 0.51 | 0.46 | 0.45 | 0.45 |
| Efficiency | ||||||
| Asset turnover | 1.18 | 1.24 | 1.17 | 1.47 | 1.46 | 1.30 |
| Inventory turnover | 4.53 | 4.78 | 4.67 | 4.49 | 4.69 | 4.83 |
| Days sales outstanding | 46d | 43d | 55d | 42d | 43d | 51d |
| Days inventory outstanding | 80d | 76d | 78d | 81d | 78d | 76d |
| Days payable outstanding | 46d | 41d | 44d | 42d | 44d | 50d |
| Cash conversion cycle | 80d | 78d | 89d | 81d | 76d | 77d |
| Valuation | ||||||
| P / E | 23.1x | 22.7x | 24.0x | 20.4x | 17.4x | 23.3x |
| P / B | 2.8x | 2.6x | 2.7x | 3.2x | 3.2x | 2.8x |
| P / S | 0.7x | 0.7x | 0.8x | 0.9x | 0.9x | 0.9x |
| EV / EBITDA | 9.4x | 9.5x | 11.4x | 12.3x | 10.4x | 12.5x |
| Growth | ||||||
| Revenue growth (YoY) | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | 13.9% |
| Revenue CAGR (3y) | 1.4% | 0.7% | 6.8% | 12.5% | -2.1% | -6.7% |
| Revenue CAGR (5y) | 5.4% | 7.4% | -1.3% | 0.3% | 1.4% | -1.0% |
| Gross profit growth (YoY) | 2.2% | 4.0% | 0.8% | 4.3% | 30.5% | -8.9% |
| Operating income growth (YoY) | 5.2% | 1.0% | -17.7% | -12.3% | 59.1% | -25.5% |
| Net income growth (YoY) | 2.1% | -6.3% | -22.7% | -14.8% | 56.3% | -41.9% |
| EPS growth (YoY) | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | -39.4% |
| EPS CAGR (3y) | -5.8% | -11.8% | 3.9% | -5.6% | 8.4% | 3.1% |
| EPS CAGR (5y) | 3.0% | -8.1% | -2.0% | 8.8% | -6.4% | -13.1% |
| FCF growth (YoY) | -18.1% | 98.3% | -30.2% | -19.8% | 14.6% | -4.8% |
| FCF CAGR (5y) | 0.8% | 3.9% | -9.9% | -2.0% | 2.9% | 1.3% |
| Book value growth (YoY) | -4.4% | -7.2% | 6.1% | 0.6% | 2.3% | 11.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-27.
Business segments
$7.05B totalGlobal Distribution And Value Added Services$4.83B · 68.5%
Global Specialty Products$1.54B · 21.9%
Global Technology$675.00M · 9.6%
Geographic
$13.18B totalUS$9.10B · 69.0%
Non Us$4.09B · 31.0%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.89
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
4/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Wholesale-Medical, Dental & Hospital Equipment & Supplies
Comparing HENRY SCHEIN INC against the 2 most active filers in the same SIC group.